Cann Group Limited (CNGGF) Stock Price & Growth Analysis

Quote Panel

Updated October 18, 2025

1W -9.09 % 1M 0.00 % 3M 0.00 % 1Y 0.00 %

Key Metrics

Market Cap
3.52M
Shares Outstanding
703.58M
Share in Float
527.81M
Dividende
0

Earning Date
No Data
Price Target
0.005
Average Volume
247
Beta
1.071

Range
0.0001-0.0386
Industry
Drug Manufacturers - Specialty & Generic
Website
https://www.canngrouplimited.com
Sector
Healthcare

Quote Panel

Updated October 18, 2025

1W % 1M % 3M % 1Y %

Key Metrics

Market Cap
Shares Outstanding
Share in Float
Dividende

Earning Date
No Data
Price Target
Average Volume
Beta

Range
Industry
Website
Sector

Fundamentals

N/A

P/E Ratio

0.74x

P/S Ratio

N/Ax

P/B Ratio

N/A

Debt/Equity

-168.6%

Net Margin

$-0.0

EPS

How CNGGF compares to sector?

P/E Ratio

Fundamentals

Relative Strength

CNGGF

Sector

Top 5 RS in Group

Symbol	Company	RS	5-Day Perf.

Relative Strength

CNGGF

Sector

Top 5 RS in Group

Symbol	Company	RS	5-Day Perf.

Forecast

N/A

2025-Revenue

N/A

2025-EPS

N/A

2025-EBITDA

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Price Target

N/A(N/A)

Number of analyst

N/A

Last analyst upgrade/downgrade

No Data Available

Forecast

Analyst rating

Last analyst upgrade/downgrade

Earnings Growth

YoY

Current

Estimates

Q1.23

N/A

NA
vs NA

Q2.23

N/A

-0.03
vs -0.04

Q3.23

N/A

NA
vs NA

Q4.23

N/A

-0.02
vs -0.04

Q1.24

N/A

NA
vs NA

Q2.24

N/A

-0.06
vs -0.03

Q3.24

N/A

NA
vs NA

Q4.24

N/A

NA
vs -0.02

Q1.25

N/A

NA
vs NA

Q2.25

+100%

NA
vs -0.06

Sales Growth

YoY

Current

Estimates

Q1.23

NA vs NA

Q2.23

+146%

8M vs 3.2M

Q3.23

NA vs NA

Q4.23

+60%

9.3M vs 5.8M

Q1.24

NA vs NA

Q2.24

+14%

9M vs 8M

Q3.24

NA vs NA

Q4.24

-31%

6.5M vs 9.3M

Q1.25

NA vs NA

Q2.25

-25%

6.8M vs 9M

Return on Equity

QoQ

Q1.23

NA
vs NA

Q2.23

-25%

-0.25
vs -0.25

Q3.23

NA
vs NA

Q4.23

-28%

-0.28
vs -0.25

Q1.24

NA
vs NA

Q2.24

-265%

-2.65
vs -0.28

Q3.24

NA
vs NA

Q4.24

-169%

-1.69
vs -2.65

Q1.25

NA
vs NA

Q2.25

+420%

4.2
vs -1.69

Institutionnal Ownership

N/A

Q3.23

NA
vs NA

Q4.23

NA
vs NA

Q1.24

NA
vs NA

Q2.24

NA
vs NA

Q3.24

NA
vs NA

Q4.24

NA
vs NA

Q1.25

NA
vs NA

Q2.25

NA
vs NA

Q3.25

NA
vs NA

Q4.25

NA
vs NA

Earnings Growth

YoY

Current

Estimates

Q1.23

N/A

NA
vs NA

Q2.23

N/A

-0.03
vs -0.04

Q3.23

N/A

NA
vs NA

Q4.23

N/A

-0.02
vs -0.04

Q1.24

N/A

NA
vs NA

Q2.24

N/A

-0.06
vs -0.03

Q3.24

N/A

NA
vs NA

Q4.24

N/A

NA
vs -0.02

Q1.25

N/A

NA
vs NA

Q2.25

+100%

NA
vs -0.06

Sales Growth

YoY

Current

Estimates

Q1.23

NA vs NA

Q2.23

+146%

8M vs 3.2M

Q3.23

NA vs NA

Q4.23

+60%

9.3M vs 5.8M

Q1.24

NA vs NA

Q2.24

+14%

9M vs 8M

Q3.24

NA vs NA

Q4.24

-31%

6.5M vs 9.3M

Q1.25

NA vs NA

Q2.25

-25%

6.8M vs 9M

Return on Equity

QoQ

Q1.23

NA
vs NA

Q2.23

-25%

-0.25
vs -0.25

Q3.23

NA
vs NA

Q4.23

-28%

-0.28
vs -0.25

Q1.24

NA
vs NA

Q2.24

-265%

-2.65
vs -0.28

Q3.24

NA
vs NA

Q4.24

-169%

-1.69
vs -2.65

Q1.25

NA
vs NA

Q2.25

+420%

4.2
vs -1.69

Institutionnal Ownership

N/A

Q3.23

NA
vs NA

Q4.23

NA
vs NA

Q1.24

NA
vs NA

Q2.24

NA
vs NA

Q3.24

NA
vs NA

Q4.24

NA
vs NA

Q1.25

NA
vs NA

Q2.25

NA
vs NA

Q3.25

NA
vs NA

Q4.25

NA
vs NA

Company Description

0.01USD

N/A

0.74x

N/Ax

N/A

-168.6%

$-0.0

N/A

N/A

N/A

Earnings Growth

Latest News

Latest News

Earnings Growth

Latest News

N/A

N/A

N/A

Company Description

0.01USD

N/A

0.74x

N/Ax

N/A

-168.6%

$-0.0